Remove Definition Remove Licensing Remove Packaging Remove Vaccine
article thumbnail

Ceracare

The Pharma Data

Definitely not! of our 3 or 6 bottle discount package. . offered by a physician or other licensed healthcare provider. Helps support your blod sugar goals and the body’s natural ability to stay healthy. Powerful anti-oxidants ingredients that help to support a Blood Circulation. very gentle yet very powerful at the same time.

article thumbnail

Unity

The Pharma Data

Definitely not! Therefore, we strongly recommend you take advantage of our 3 or 6 bottle discount package. . offered by a physician or other licensed healthcare provider. Helps support your weight loss goals and the body’s natural ability to stay healthy. Powerful anti-oxidants ingredients that help to support a healthy heart*.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis Life Sciences Thank You The U.S. regulatory landscape for probiotics and other microbiome-based therapies

Agency IQ

Unfortunately, there is no regulatory body that governs the terminology used in this space, although there are definitions that are generally accepted by the scientific community. Postbiotic: “Preparation of inanimate micro-organisms and/or their components that confers a health benefit on the host,” according to the ISAPP definition.

article thumbnail

Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results

The Pharma Data

See “Reconciliation of Non-GAAP Measures” for a definition of the terms and reconciliation tables.). • Anthrax Vaccines. ACAM2000 ® , (Smallpox (Vaccinia) Vaccine, Live) vaccine deliveries are expected to continue under the terms of the Company’s existing contract with the U.S. .

article thumbnail

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses

The Pharma Data

“Tackling the COVID-19 pandemic will require a combination of public health measures, vaccines and therapeutics. Definition of High-Risk Patients. . “COVID-19 continues to sicken hundreds of thousands of Americans every day and the people of Regeneron are committed to help,” said Leonard S. Schleifer , M.D.,

article thumbnail

Analysis Life Sciences Thank You FDA fiscal year in review: New drug approvals in the wake of the pandemic and legislative reforms

Agency IQ

As such, it doesn’t review things like vaccines, blood products or gene therapies – those products are instead reviewed by CBER. All products are received in one of two forms: A New Drug Application (or NDA, for pharmaceuticals) or a Biologics License Application (BLA, for biologics). What’s next? Stay tuned.

FDA 52
article thumbnail

Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to Receive FDA Emergency Use Authorization

The Pharma Data

We are also very encouraged by recently announced promising vaccine results; however, there remains a need to treat patients who develop COVID-19, especially as some may not have had access to or were not protected by vaccination. Definition of High-Risk Patients. Have chronic kidney disease. Are ?